Replies to post #4360 on Quanta Inc (fka QNTA)

[Dragon Lady]

QNTA: NOVEL_NEW_CANCER_TREATMENT_PATENT +SALES_IN_OVER_40_NATIONS !

https://www.globenewswire.com/news-release/2021/04/29/2219682/0/en/Medolife-Rx-Breaks-Ground-on-Lab-Facility-and-Increases-Scorpion-Count-at-First-of-Its-Kind-Reservation-in-the-Dominican-Republic.html

QNTA OWNS THAT COMPANY NOW - and they BROKE GROUND on a massive new state of the art manufacturing facility and "scorpion farm" for producing MEDICAL SERUMS for a whole slew of CANCER TREATMENTS !

And NATIONAL CANCER INSTITUTES support and backs their "BLUE SCORPION SERUM" (YES, the "venom serum" a scorpion produces when it stings a person!) for cancer treatments- of which QNTA via their wholly owned subsidiary MedoLife is now thee WORLD PRODUCER and PATENT HOLDER - it's mind boggling how high this will go when the market cap reaches FAIR VALUE !

https://www.nfcr.org/blog/scorpion-venom-the-newest-treatment-for-a-deadly-cancer/

THAT = one of thee world's leading CANCER RESEARCH FOUNDATIONS and QNTA now holds the patent and most of the WORLD SUPPLY to "making BLUE SCORPION BASED SERUMS" !!

https://medolife.com/history/

QNTA OWNS that company now- and THE PATENTS !!

QUOTE:

"In 2010, Medolife received its first Registration for its product, Escozine, in the Dominican Republic. Medolife received a full Patent in 2012. This exclusive patent license, (United States patent # 8,097,284 B2) is being used to make a new generation of nutraceuticals and drugs utilizing the polarization technology for higher potency bioactive peptides.

Escozine™ is registered and certified for oncological treatment by the Minister of Health in the Dominican Republic. Escozine™ is currently sold through direct online marketing to over 40 countries and is currently registered in six countries (Dominican Republic, Vietnam, Russia, Belarus, Kazakhstan, Nigeria, and Armenia) as well as being sold in the United States as a nutraceutical."


This is SOoooo under the radar here it's not even funny - it's a $BUCK A SHARE STOCK just for starters folks.

QNTA via RECENT MERGER with MedoLife Rx OWNS THE DAMN PATENTS NOW !!

[Dragon Lady]

$QNTA: CANCER_TREATMENT "SCORPION_VENOM" = REAL_MEDICAL_RESEARCH !

https://www.barchart.com/story/news/1692886/Medolife-Rx-Announces-New-Extraction-Facility-and-Scientific-Team-in-Place

This is going to a $BUCK A SHARE as the market cap and float is PALTRY HERE !

Folks - the use of SCORPION SERUMS is as REAL AS IT GETS - it's no damn joke !!!

Check PubMED THEE USA and WORLD RESEARCH REPOSITORY - and TONS of high level CANCER CENTER RESEARCH exists on "SCORPION VENOM" and other unique venom serums due to their natural peptide and protein structures !!!

https://www.hindawi.com/journals/mi/2010/903295/

AND NATIONAL INSTITUTE OF HEALTH - thee PREMIER USA MED RESEARCH ARM !

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7130864/

QNTA VIA THEIR WHOLLY OWNED SUBSIDIARY MedoLife Rx NOW OWNS THE FREAKING PATENT for SCORPION SERUM for SPECIFIC CANCER TREATMENTS FOLKS !!

LET THAT FREAKING SINK IN PEOPLE -

https://medolife.com/history/

THAT COMPANY is now 100% OWNED BY $QNTA !!

Here is THEE NATION FOUNDATION FOR CANCER RESEARCH - a freaking WORLD LEADING ORGANIZATION and THEY are discussing "USE OF BLUE SCORPION SERUM TO TREAT A VARIETY OF CANCER TUMORS" !!!

https://www.nfcr.org/blog/scorpion-venom-the-newest-treatment-for-a-deadly-cancer/

$QNTA OWNS THOSE PATENTS NOW - GET IF FOLKS :)))

This is BEYOND HUGE - QNTA has a paltry $20 MILLION market cap for a $BILLION DOLLAR NEW CANCER TREATMENT in WORLD CLINICAL TRIALS already = mind boggling !!!

QNTA just EXPANDED A FACILITY - in the Dominican Republic (GREAT SITE for medical R&D - VERY research friendly nation !) and to RAISE AND EXPAND THEIR "BLUE SCORPION FARM" for more, more more SERUM - as this market is about to go WORLD WIDE !!!

QNTA already sells this CANCER TREATMENT TO MD DOCTORS in over 40 countries and is currently registered in six countries (Dominican Republic, Vietnam, Russia, Belarus, Kazakhstan, Nigeria, and Armenia) as well as being sold in the United States as a nutraceutical.